SADS Live

Since the beginning of the COVID-19 pandemic, we wanted to bring the SADS community together during some uncertain times.

We’ve started SADS live streaming on Facebook then expanded to Twitter and YouTube every Friday straight to your home and answering your SADS-related questions. Dr. Michael Ackerman and his guests have provided expert answers to questions about life with SADS conditions – from meeting medical experts, researchers, and community members, and asking questions about your cardiac condition.

As things slowly return to normal, we’re planning to bring you SADS Live twice a month now (rather than every Friday).

Below are a few of our favorite episodes. To see the full list of episodes, check out SADS Youtube Channel,  join us on facebook @SuddenArrhythmiaDeathSyndromesFoundation or follow us on Twitter.

#160  SADS Live: Top 5 Research papers of 2024

Join Drs. Ackerman and Landstorm in discussing the top 5 research papers of 2024. Check out the papers below:

1. Declining Trend of Sudden Cardiac Death in Younger Individuals: A 20-Year Nationwide Study by Carl Johann Hansen, MD, PhD et al., showed the rates of sudden cardiac death in young individuals declined by 49% in the last 20 years. 
2. Multisite Validation of a Functional Assay to Adjudicate SCN5A Brugada Syndrome– Associated Variants by Andrew M. Glazer, PhD et al., looked at ways to help classify SCN5A-Brugada syndrome variants of uncertain significance.
3. A Rare Noncoding Enhancer Variant in SCN5A Contributes to the High Prevalence of Brugada Syndrome in Thailand by Roddy Walsh, PhD et al., looked at a specific SCN5A variant that is particularly prevalent in Thailand and is associated with severe Brugada Syndrome. 
4. Antisense oligonucleotide therapeutic approach for Timothy syndrome by Xiaoyu Chen et al. looked at a potential therapeutic strategy for Timothy Syndrome.
5. KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome by Sahej Bains et al. shows that suppression-replacement gene therapy in LQT1 rabbits significantly shortens the QT interval